✦ LIBER ✦

Antiviral therapy: chronic hepatitis C

✍ Scribed by E. Jenny Heathcote

Book ID: 108886075
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 80 KB
Volume: 14
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2007.00921.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New antiviral therapies for chronic hepa

New antiviral therapies for chronic hepatitis C

✍ Tatsuo Kanda; Fumio Imazeki; Osamu Yokosuka 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 387 KB

Adherence to antiviral therapy in chroni

Adherence to antiviral therapy in chronic hepatitis C

✍ Keyur Patel; Anouk T. Dev 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 353 KB

Individualisation of antiviral therapy f

Individualisation of antiviral therapy for chronic hepatitis C

✍ Narci C Teoh; Geoffrey C Farrell; Henry L-Y Chan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Antiviral therapy for chronic hepatitis

Antiviral therapy for chronic hepatitis C: past, present, and future

✍ Norio Hayashi; Tetsuo Takehara 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 220 KB

ChemInform Abstract: Antiviral Therapy f

ChemInform Abstract: Antiviral Therapy for Chronic Hepatitis C: Current Status and Perspectives

✍ Tetsuo Takehara 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 15 KB 👁 2 views

Serum HBeAg quantitation during antivira

Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B

✍ Heijtink, Rudolf A.; Kruining, Johannes; Honkoop, Pieter; Kuhns, Mary C.; Hop, W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Hepatitis Be antigen (HBeAg) seroconversion is considered the principal short-term goal of antiviral therapy in chronic hepatitis B. To test whether the pre-and per-treatment HBeAg quantitation has a higher predictive value than that of hepatitis B virus DNA (HBV-DNA) quantitation for the outcome of